Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Chung-Ang University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Gyeongsang National University Hospital
Information provided by:
Chung-Ang University
ClinicalTrials.gov Identifier:
NCT01170104
First received: July 23, 2010
Last updated: June 22, 2011
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)